Screening and Etiology of Congenital Heart Disease in Developing Countries : A Comprehensive Systematic Review
Keywords:
prenatal screening, postnatal screening, etiology, congenital heart diseaseAbstract
Introduction: The increasing number of newborns with congenital heart disease (CHD) shows that the global burden of CHD is still significant. This indicates that screening and prevention have not been carried out optimally. This study aims to determine the differences of screening and etiology of congenital heart disease (CHD) between developed and developing countries. Methods: A systematic review adhering to PRISMA 2020 guidelines was conducted. Studies from 2015 to 2025 focusing on the screening and etiology of CHD in developing and developed countries were included. Results: Twenty-three relevant studies were included. Combination of pulse oximetry (PO) and auscultation, or PO alone were the most common postnatal screening tools in developed and developing countries. For prenatal screening, ultrasound was commonly used. Artificial intelligence and genetic testing were only used in developed countries. The etiology such as genetics, maternal lifestyle or conditions were discussed. Conclusion: The urgent need for affordable early detection of congenital heart disease (CHD) in developing countries cannot be overstated, as it holds the potential to significantly reduce the global burden of this condition. By implementing comprehensive prenatal and postnatal screening programs, we can identify at-risk infants early, enabling timely interventions and improved health outcomes. Addressing this critical issue not only enhances individual lives but also strengthens healthcare systems and fosters healthier communities.
References
Triedman JK, Newburger JW. Trends in congenital heart disease. Circulation. 2016 Jun 21;133(25):2716–33.
Froehlich RJ, Maggio L, Has P, Werner EF, Rouse DJ. Evaluating the Performance of Ultrasound Screening for Congenital Heart Disease: A Descriptive Cohort Study. Am J Perinatol. 2017 Jul 1;34(9):905–10.
van Velzen C, Clur S. Prenatal detection of congenital heart disease— results of a national screening programme. Vol. 123, BJOG: An International Journal of Obstetrics and Gynaecology. 2016. p. 408.
Zimmerman MS, Smith AGC, Sable CA, Echko MM, Wilner LB, Olsen HE, et al. Global, regional, and national burden of congenital heart disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Child Adolesc Health. 2020 Mar 1;4(3):185–200.
de Vries IR, van Laar JOEH, van der Hout-van der Jagt MB, Clur SAB, Vullings R. Fetal electrocardiography and artificial intelligence for prenatal detection of congenital heart disease. Acta Obstet Gynecol Scand. 2023 Nov 1;102(11):1511–20.
Engel MS, Kochilas LK. Pulse oximetry screening: A review of diagnosing critical congenital heart disease in newborns. Vol. 9, Medical Devices: Evidence and Research. Dove Medical Press Ltd; 2016. p. 199–203.
Bahtiyar MO, Copel JA. Screening for Congenital Heart Disease During Anatomical Survey Ultrasonography. Vol. 42, Obstetrics and Gynecology Clinics of North America. W.B. Saunders; 2015. p. 209–23.
Atitlán-Gil A, Mendiola-Figueroa LR, Morales-Argüelles VH, Salomón-Ganado A, Medécigo-Castelán E, Erdmenger-Orellana J. Implementation of diagnostic screening for congenital heart disease in Hidalgo, Mexico. Archivos de cardiolog�a de M�xico (English ed Internet). 2020 May 19;90(1).
Cody F, Franklin O, Mc Cay N, Molphy Z, Dicker P, Breathnach FM. Critical congenital heart disease: contemporary prenatal screening performance and outcomes in a multi-centre perinatology service. BMC Pregnancy Childbirth. 2024 Dec 1;24(1).
Choudhury TZ, Garg V. Molecular genetic mechanisms of congenital heart disease. Vol. 75, Current Opinion in Genetics and Development. Elsevier Ltd; 2022.
Dinarti LK, Murni IK, Anggrahini DW, Dewanto VC, Pritazahra A, Hadwiono MR, et al. The screening of congenital heart disease by cardiac auscultation and 12-lead electrocardiogram among Indonesian elementary school students. Cardiol Young. 2021 Feb 1;31(2):264–73.
Gireadă R, Socolov D, Mihălceanu E, Matasariu R, Ursache A, Akad M, et al. The Additional Role of the 3-Vessels and Trachea View in Screening for Congenital Heart Disease. Medicina (Lithuania). 2022 Feb 1;58(2).
Hamilçikan Ş, Can E. Critical congenital heart disease screening with a pulse oximetry in neonates. J Perinat Med. 2018 Feb 23;46(2):203–7.
Helle E, Priest JR. Maternal obesity and diabetes mellitus as risk factors for congenital heart disease in the offspring. J Am Heart Assoc. 2020 Apr 21;9(8).
Hu XJ, Ma XJ, Zhao QM, Yan WL, Ge XL, Jia B, et al. Pulse Oximetry and Auscultation for Congenital Heart Disease Detection. Pediatrics [Internet]. 2017; Available from: http://pediatrics.aappublications.org/
Huang Y, Zhong S, Zhang X, Kong L, Wu W, Yue S, et al. Large scale application of pulse oximeter and auscultation in screening of neonatal congenital heart disease. BMC Pediatr. 2022 Dec 1;22(1).
Jain D, Jain M, Lamture Y. Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates. Cureus. 2022 Dec 23;
Janicki MB, Fernandez CG, Wakefield D, Shepherd JP, Figueroa R. Improving fetal congenital heart disease screening using a checklist-based approach. Prenat Diagn. 2020 Jan 1;40(2):223–31.
Janjua D, Singh J, Agrawal A. Pulse oximetry as a screening test for congenital heart disease in newborns. J Mother Child. 2022 Mar 1;26(1):1–9.
Li JJ, Liu Y, Xie SY, Zhao GD, Dai T, Chen H, et al. Newborn screening for congenital heart disease using echocardiography and follow-up at high altitude in China. Int J Cardiol. 2019 Jan 1;274:106–12.
Ma X, Tian Y, Ma F, Ge X, Gu Q, Huang M, et al. Impact of Newborn Screening Programme for Congenital Heart Disease in Shanghai: a five-year observational study in 801,831 newborns. Lancet Reg Health West Pac. 2023 Apr 1;33.
Mires S, Caputo M, Overton T, Skerritt C. Maternal micronutrient deficiency and congenital heart disease risk: A systematic review of observational studies. Vol. 114, Birth Defects Research. John Wiley and Sons Inc; 2022. p. 1079–91.
Murni IK, Wibowo T, Arafuri N, Oktaria V, Dinarti LK, Panditatwa D, et al. Feasibility of screening for critical congenital heart disease using pulse oximetry in Indonesia. BMC Pediatr. 2022 Dec 1;22(1).
Ngeow AJH, Tan MG, Choo JTL, Tan TH, Tan WC, Chan DKL. Screening for congenital heart disease in a Singapore neonatal unit. Vol. 62, Singapore Medical Journal. Singapore Medical Association; 2021. p. 341–6.
Siefkes H, Kair L, Tancredi DJ, Vasquez B, Garcia L, Bedford-Mu C, et al. Oxygen Saturation and Perfusion Index-Based Enhanced Critical Congenital Heart Disease Screening. Am J Perinatol. 2020;37(2):158–65.
El Idrissi Slitine N, Bennaoui F, Sable CA, Martin GR, Hom LA, Fadel A, et al. Pulse oximetry and congenital heart disease screening: Results of the first pilot study in Morocco. Int J Neonatal Screen. 2020 Jun 30;6(3).
Tsao PC, Chiang SH, Shiau YS, Chen HY, Lin HL, Ho HC, et al. Comparing Strategies for Critical Congenital Heart Disease Newborn Screening. Pediatrics. 2023 Mar 1;151(3).
Yang H, Pan J, Wang W, Guo T, Ma T. Application of Artificial Intelligence-Based Auxiliary Diagnosis in Congenital Heart Disease Screening. Anatol J Cardiol. 2023 Apr 1;27(4):205–16.
Zhang M, Chen J, Zhang H, Guo Y, Zhang Q. Prenatal ultrasound monitoring and diagnostic accuracy rates of fetal congenital heart disease: A meta-analysis. Afr J Reprod Health. 2023 Jun 1;27(6):33–40.
Zhang J, Xiao S, Zhu Y, Zhang Z, Cao H, Xie M, et al. Advances in the Application of Artificial Intelligence in Fetal Echocardiography. Vol. 37, Journal of the American Society of Echocardiography. Elsevier Inc.; 2024. p. 550–61.
Sun RR, Liu M, Lu L, Zheng Y, Zhang P. Congenital Heart Disease: Causes, Diagnosis, Symptoms, and Treatments. Cell Biochem Biophys. 2015 Jul 1;72(3):857–60.
Meng X, Song M, Zhang K, Lu W, Li Y, Zhang C, et al. Congenital heart disease: types, pathophysiology, diagnosis, and treatment options. Vol. 5, MedComm. John Wiley and Sons Inc; 2024.
Chaix MA. Genetic testing in congenital heart disease: A clinical approach. World J Cardiol. 2016;8(2):180.
Chamsi-Pasha MA, Chamsi-Pasha H. Critical congenital heart disease screening. Avicenna J Med. 2016 Jul;06(03):65–8.
Martin GR, Ewer AK, Gaviglio AML, Hom LA, Saarinen AM, Sontag MP, et al. Updated strategies for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2020 Jul 1;146(1).
Bruno CJ, Havranek T. Screening for Critical Congenital Heart Disease in Newborns. Vol. 62, Advances in Pediatrics. Academic Press Inc.; 2015. p. 211–26.
Oster ME, Kochilas L. Screening for Critical Congenital Heart Disease. Vol. 43, Clinics in Perinatology. W.B. Saunders; 2016. p. 73–80.
Marek J, Tomek V, Škovránek J, Povýšilová V, Šamánek M. Prenatal ultrasound screening of congenital heart disease in an unselected national population: A 21-year experience. Heart. 2011 Jan;97(2):124–30.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dzakiyyah Fiddin, Dhanista Hastinata Sukarna Putra, Irkhamyudhi Primasakti (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
